Open main menu
Search Ctrl + K
Free Trial
Loading...
Rain Oncology Inc.
Watch
Pharmaceutical Preparations
NASDAQ.RAIN
8000 Jarvis Avenue, Suite 204, Newark, CA, 94560
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
19 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
19 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
20 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
20 Apr 22
News
8-K
Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modifications To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
26 Jan 24
8-K
Other Events
19 Jan 24
8-K
Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
14 Dec 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
09 Nov 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
10 Aug 23
8-K
Cost Associated With Exit Or Disposal Activities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Financial Statements And Exhibits
05 Jun 23
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
22 May 23
Prospectuses and Registrations
S-8 POS
Post-effective Amendment To An S-8 Filing.
26 Jan 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
26 Jan 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
26 Jan 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
26 Jan 24
POS AM
Post-effective Amendment To An S-1 Or Other Registration Form.
26 Jan 24
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
26 Jan 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
16 Jan 24
Financials
10-Q
Quarterly Filing
09 Nov 23
10-Q
Quarterly Filing
10 Aug 23
10-Q
Quarterly Filing
11 May 23
10-K
Fiscal Year 2022
09 Mar 23
10-Q
Quarter 3
10 Nov 22
10-Q
Quarterly Filing
04 Aug 22
10-Q
Quarterly Filing
04 May 22
Other
15-12G
Certification And Notice Of Termination Of Registration Under Section 12(g) Or Suspension Of Duty To File Reports.
05 Feb 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
30 Jan 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
26 Jan 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
22 Jan 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
16 Jan 24
SC 14D9
Solicitation/recommendation Statement Under Section 14(d)(4) Of The Exchange Act.
27 Dec 23
SC 14D9
Solicitation/recommendation Statement Under Section 14(d)(4) Of The Exchange Act.
14 Dec 23
Ownership
SC 13G/A
14 Feb 24
SC 13G/A
14 Feb 24
SC 13G/A
07 Feb 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
02 Feb 24
4
Tang Kevin C
02 Feb 24
4
Bvf Partners L P/il
29 Jan 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
29 Jan 24